Docusign Appoints Rowan Trollope, Former Five9 CEO, to Board of Directors
DOCU sits 16% above its 52-week low of $40.16.
Summary
Docusign appointed Rowan Trollope, a veteran technology executive with expertise in AI and enterprise software, to its Board of Directors, effective May 2, 2026.
Key Events · Executive and Board Changes · DOCU
-
New Director Appointed
Rowan Trollope was appointed as an independent Class III director to Docusign's Board of Directors, effective May 2, 2026.
-
Extensive Industry Experience
Mr. Trollope brings significant experience as CEO of Redis, Inc. (a database services company focused on AI applications) and former CEO of Five9, Inc., along with executive roles at Cisco Systems, Inc. and prior board positions at Smartsheet and VeriFone Systems, Inc.
-
Strategic Alignment
His expertise in AI, cybersecurity, and enterprise software, coupled with his public company CEO and board experience, is expected to support Docusign's Intelligent Agreement Management strategy.
Analysis · DOCU · Technology
This appointment strengthens Docusign's Board with a seasoned technology executive. Mr. Trollope's background as CEO of Redis, Inc. (focused on AI applications) and former CEO of Five9, Inc., along with his experience in enterprise software and cybersecurity, aligns well with Docusign's strategic focus on intelligent agreement management and leveraging agreement data. His public company leadership and board experience are valuable additions, providing relevant expertise to guide the company's future initiatives.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1594 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DOCU was trading at $46.64 on NASDAQ in the Technology sector, with a market capitalization of approximately $9B. The 52-week trading range was $40.16 to $94.67. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.